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Introduction
For much of the history of the HIV/AIDS epidemic in 
Massachusetts, injection drug use (IDU) has been a leading 
mode of HIV transmission. Injection drug use not only contributes 
to the spread of HIV through the sharing of needles, syringes 
and other equipment among those who inject, but also through 
transmission to the sexual partners of injection drug users. There 
are encouraging signs injection drug users have substantially 
reduced their risk of transmission of HIV.  
Please note that for the purposes of this fact sheet injection 
drug use (IDU) exposure mode includes both IDU and male-to-
male sex (MSM) and IDU (MSM/IDU) unless otherwise stated.
General Statistics:
As of December 31, 2008, 28% (N=4,902) of people living with •	
HIV/AIDS (PLWH/A) were reported with IDU as an exposure 
mode. An additional 5% (N=939) of PLWH/A were reported 
to be exposed to HIV through heterosexual sex with an 
injection drug user. One-hundred and nine children living as 
of December 31, 2008 were born to HIV-infected mothers who 
injected drugs and/or had sex with an injection drug user.
Among people diagnosed with HIV infection within the three-•	
year period 2005 to 2007, 16% (N=355) were reported to be 
exposed to HIV through IDU and an additional 3% (N=59) 
were reported to be exposed through heterosexual sex with 
an injection drug user. 
The proportion of people diagnosed with HIV infection who •	
were reported to be exposed to HIV through IDU (not including 
those with a history of male-to-male sex) decreased from 29% 
in 1999 to 15% in 2007. i
Regional Distribution:
IDU was the leading reported mode of exposure in the Central 
and Western Health Service Regions ii  among people living with 
HIV/AIDS. However, among people diagnosed with HIV infection 
within the three-year period 2005 to 2007, IDU was the leading 
mode of exposure in none of the Health Service Regions of the 
Commonwealth.
Among cities with over 20 people diagnosed with HIV infection 
within the three-year period 2005 to 2007, the following have 
the highest proportions of infection with all IDU as the reported 
mode of exposure (N=number with IDU and MSM/IDU as 
exposure mode):
Holyoke  41% (N=16)•	
New Bedford 30% (N=17)•	
Springfield	 30%	 (N=42)•	
Chicopee 22% (N=5)•	
Worcester 18% (N=21)•	
Lowell  17% (N=10)•	
Lawrence 17% (N=9)•	
Somerville 16% (N=8)•	
Framingham 15% (N=5)•	
Fall River 15% (N=3)•	
Population	Specific
Fact Sheets
Figure 1. Percentage Distribution of People Diagnosed with 
HIV Infection by Exposure Mode and Year of Diagnosis: 
MA, Before 1999, 1999–20071
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Note: a dashed line is used to distinguish between pre-1999 data (which is an aggregate of multiple years) and annual data for 
subsequent years. 1 2007 data are preliminary; The transition to name-based reporting has resulted in a delay in finalizing the dataset 
for 2007 ; Data Source: MDPH HIV/AIDS Surveillance Program; Data as of 1/1/09
Massachusetts HIV/AIDS Data Fact Sheet
Injection Drug Users
For detailed data tables and technical notes see Appendix 
Massachusetts Department of Public Health Office of HIV/AIDS  
250 Washington St. 3rd Floor Boston, MA 02108
 617-624-5300       FAX 617-624-5399       www.mass.gov/dph/aids
Page 2 of 3
Gender:
Of 4,902 PLWH/A who were reported exposed to HIV through •	
all IDU, 72% were male and 28% were female. Likewise, 
among people diagnosed with HIV infection within the three-
year period 2005 to 2007 with all IDU exposure, 72% were male 
and 28% were female. This mirrors the overall male/female 
distribution of prevalent HIV/AIDS cases in Massachusetts.
Among PLWH/A with IDU-related exposures, such as •	
heterosexual sex with an injection drug user and being a child 
born to an HIV-infected mother who injected drugs or had sex 
with an injection drug user, females accounted for 77% and 
males 23% of cases. Females accounted for 64% of recent 
IDU-related HIV diagnoses and males 36%.
Race/Ethnicity:
Thirty-nine percent of PLWH/A on December 31, 2008 with a •	
reported exposure mode of IDU were white (non-Hispanic), 
23% were black (non-Hispanic), 37% were Hispanic and 
1% were of other race/ethnicities. Similarly, among people 
diagnosed with HIV infection within the three-year period 
2005 to 2007, with a reported exposure mode of IDU, 43% 
were white (non-Hispanic), 17% were black (non-Hispanic), 
39% were Hispanic and 1% were of other race/ethnicities.
Of females living with HIV/AIDS with a reported exposure •	
mode of IDU, 48% were white (non-Hispanic), compared to 
36% of males, and 29% were Hispanic, compared to 40% of 
males. Twenty-three percent of both males and females were 
black (non-Hispanic). 
Age:
Among persons diagnosed with HIV infection within the three-•	
year period 2005 to 2007, those with a reported exposure mode 
of IDU were less likely to be adolescents/young adults than 
those with other modes of exposure. Four percent of injection 
drug users diagnosed with HIV infection within the three-year 
period 2005 to 2007 were 13–24 years old compared to 9% of 
people exposed to HIV through other modes.
On December 31, 2008, 1% of PLWH/A exposed to HIV •	
infection through IDU were under 30 years old, compared to 
7% of PLWH/A exposed through other modes of exposure. 
Among PLWH/A exposed to HIV infection through IDU, 12% 
were 30-39 years old (compared to 20% of those exposed 
through other modes); 47% were 40-49 years old (compared 
to 41%); 35% were 50-59 years old (compared to 24%); 5% 
were age 60 years or above (compared to 8%). 
HIV-Related Morbidity and Mortality among IDU:
AIDS Diagnoses:	 An	 AIDS	 diagnosis	 signifies	 disease	
progression and may be an indicator of late HIV diagnosis, 
delayed entry to medical care, treatment failure, or limited 
access to medical care. 
From 1998 to 2003, injection drug use (not including those •	
with a history of male-to-male sex) accounted for the largest 
number of AIDS diagnoses among exposure modes. In 2004 
the number of AIDS diagnoses attributed to injection drug use 
and male-to-male sex was equal (N=163). From 2005 to 2007 
the number of AIDS diagnoses attributed to injection drug use 
has fallen below the number attributed to male-to-male sex.
Mortality with AIDS
From 1998 to 2007, the proportion of deaths among people •	
diagnosed with AIDS represented by those exposed to HIV 
infection through IDU ranged from 55% to 45%.
Figure 2. Percent of Deaths among Persons Reported with 
AIDS by Mode of Exposure and Year of Death: 
Massachusetts, 1985–20071
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Note: a dashed line is used to distinguish between data points that span multiple years and annual data points for subsequent 
years. Data Source: MDPH HIV/AIDS Surveillance Program; 1 2007 Data are preliminary Data as of 1/1/09
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Injection Drug Use among Youth in High School:
In 2007, 2.5% of all respondents to the Massachusetts Youth •	
Risk Behavior Survey reported ever using a needle to inject 
an illegal drug. 
As in prior years, in 2007, injection drug use was more •	
common among males (3.3%) than among females (1.6%) 
but did not vary substantially by grade.
Injection Drug Use among Program Participants:
Needle Exchange Participants
Among 1,996 participants in state-funded needle exchange •	
programs	in	state	fiscal	year	2008,	33%	reported	being	under	
age	20	years	at	first	injection.
Substance Abuse Admissions
From	 state	 fiscal	 years	 1999	 to	 2008,	 the	 percentage	 of	•	
admissions to state-funded substance abuse treatment 
programs reporting the use of a needle to inject drugs within 
a year of admission rose from 25% to 32%. The number of 
admissions reporting needle use within one year increased 
11%	from	29,437	in	fiscal	year	1999	to	32,568	in	fiscal	year	
2008.
From	 state	 fiscal	 years	 1999	 to	 2008,	 the	 percentage	 of	•	
admissions to state-funded substance abuse treatment 
programs for heroin addiction increased from 32% to 37% 
of total admissions. During this time period, the number of 
admissions for heroin use decreased slightly from 37,352 in 
fiscal	year	1999	to	36,803	in	fiscal	year	2008.
Ninety percent of admissions to state-funded substance •	
abuse	 treatment	programs	 in	fiscal	year	2008	who	reported	
needle use within the past year were unemployed, compared 
to 69% of admissions who did not report needle use; 33% 
were homeless compared to 18% of admissions who did not 
report needle use.
Data Sources:
HIV/AIDS Case Data: Massachusetts Department of Public Health (MDPH) 
HIV/AIDS Surveillance Program; data as of January 1, 2009 
YRBS Data: Massachusetts Department of Elementary and Secondary 
Education, 2007 Youth Risk Behavior Survey Results
Needle	Exchange	Data:	MDPH	Office	of	HIV/AIDS,	Prevention	and	Education	
Program
Substance Abuse Admissions: MDPH Bureau of Substance Abuse Services 
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i Caution should be exercised when considering changes in trends for 2007. 
Implementation of a new reporting system in 2007 may have led to differential 
reporting within race/ethnicity, gender and exposure mode as providers serving 
various populations reported at different rates at the beginning of the new 
reporting system.
ii	HSRs	are	regions	defined	geographically	to	facilitate	targeted	health	service	
planning.	 See	 Epidemiologic	 Profile	 General	 Appendices,	 Health	 Service	
Region Maps, available at http://www.mass.gov/Eeohhs2/docs/dph/aids/2006_
profiles/app_hrs_maps.pdf	for	configuration	of	health	service	regions.	Reflects	
the health service region of a person’s residence at the time of report (not 
necessarily current residence).
